Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Clinical trial NCT06409130 · COMPLETED
Trial details
- NCT number
- NCT06409130
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-11-21
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.